Analysis of hydroxychloroquine dosage in hospitalized COVID-19 patients shows low-dose benefits and high-dose risks.

Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday ...

FDA ends hydroxychloroquine authorization for coronavirus 00:39. Hydroxychloroquine should not be used to prevent or treat COVID-19, the World Health Organization (WHO) advised this week.The anti ...

Hydroxychloroquine, an anti-malarial drug used to treat autoimmune diseases like rheumatoid arthritis for decades, is not a cure for COVID-19. A swath of studies, ...

The malaria drug hydroxychloroquine – which President Trump said he took in the hope of warding off Covid-19 – was found not to prevent infections among volunteers in a study released on ...

Democratic senators want to know what's been done to stop unproven treatment. Nursing homes in Texas and Pennsylvania administered hydroxychloroquine to residents battling novel coronavirus ...

Hydroxychloroquine and Other Autoimmune Drugs Don’t Fully Protect Against Coronavirus, Early Data Suggest. Share. Resize. Advertisement. This copy is for your personal, non-commercial use only.

Hydroxychloroquine returns as wedge between President Trump, health advisers. In "20/20" special, FDA commissioner says the drug has become politicized.

Hydroxychloroquine, a drug promoted by Trump, failed to prevent healthy people from getting covid-19 in trial. The University of Minnesota enrolled health-care workers and others exposed to the ...

WASHINGTON – The U.S. Food and Drug Administration revoked its emergency authorization for hydroxychloroquine, a controversial malaria drug promoted by President Donald Trump for treating the ...

Trump first touted hydroxychloroquine as a potential treatment for COVID-19 at a task force news briefing March 19 after initial reports of its success, saying it "could be a game-changer." ...

Cavalcanti at al. conclude that the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status among patients who had been hospitalized with mild-to-moderate Covid-19.